MetAlert Inc (MLRT)

[sweet crude]

GTXO upgraded to .25+

https://ludlowresearch.com/updates/f/gtxo-upgrade-to-20-price-on-launch-of-fda-covid-test-kits

(NEW YORK)--Ludlow Research upgrades its opinion on GTX Corp (OTCQB: GTXO), a pioneer in the field of wearable GPS, with a new ‘speculative’ target of $0.20 to $0.25+ based on launch of COVID-19 Antigen rapid test kits.

Months ago we upgraded our price target on GTXO of $0.08 to $0.10, which was achieved on Jan 26, 2021. Based on new policy changes at federal level, Ludlow Research has upgraded its short-term price range on GTXO to $0.20 to $0.25+ on improving fundamentals, and launch of new antibody and COVID-19 antigen test kits.

A critical component of the COVID-19 vaccine roll-out will be testing, for both antibodies or current infection status of COVID-19. These types of tests may become a standard for workplaces, such as restaurants and transportation, by providing quick validation of antibody protection or current infection of individuals seeking to interact with customers and public at large.

Unlike antibody tests, the company's new FDA approved rapid Antigen test kits provide information if an individual is currently infected with the COVID-19 virus in as little as 10-minutes.

The CDC and U.S. Department of Transportation (USDOT) recently considered requiring negative COVID test results to board domestic air flights before pulling back under pressure from the air travel industry. But this shows going forward there could be many scenarios where providing a 'negative' COVID test on the spot may be required as things move forward with reopening through summer.

Based on recent federal policy changes, low market valuation, profitable status, and increasing retail investor demand, we believe GTXO now has upside potential from its current $0.07 price to $0.20 to $0.25+ per share.

Key reasons for coverage:

- Launch of FDA approved antibody/antigen test kits
- Face mask mandates, policy changes
- Demand for testing at home and offices
- Customers in over 35 countries
- U.S. Government & Military supplier
- Profitable, higher revenue outlook
- Low Valuation compared to peers

Register for Email and SMS text alerts on this report
https://ludlowresearch.com/alerts